Culminating Project Title
Date of Award
Culminating Project Type
Rehabilitation Counseling: M.S.
Community Psychology, Counseling and Family Therapy
School of Health and Human Services
Dr. Amy Knopf
Dr. Susan Dowds
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Keywords and Subject Headings
opioid(s), buprenorphine, methadone, medicated assisted treatment, length of treatment, harm reduction, counseling.
Opioid addiction has been on the rise since 1990, when physicians began administering prescription pain medications. The population has undergone a drastic change from opioid prescriptions such as oxycodone to illicit forms, such as heroin, to aid pain management. Illegal opiates became the alternative drug at a lower cost to fulfill cravings and dependence that prescriptions may no longer feed. With a rise in dependence, pharmaceutical laboratories developed medicated assistant treatments (MAT) to aid in this crisis, more formally known as buprenorphine and methadone. Studies conducted show evidence of a decrease in illicit opioid use when using these medicated treatments and can lead to successful retention of the addiction. The users' experiences are often overlooked in terms of how administration occurs and when the taper of these therapies begins. Anecdotal findings suggest that prescribers continue to prescribe medications with intended harm reduction approaches instead of focusing on abstinence. This study focuses on the history of opioid prescription, addiction, and medical information regarding medication therapy, harm reduction, and the deliverance of why persons administered MAT has been prescribed for an extended amount of time. This study focuses on who is primarily responsible for the length of MAT treatment. Interviews with persons previously or currently prescribed medication-assisted treatment will initiate personal experiences to conclude whether the client or physician controls MAT administration length. Recommendations of participants will be discussed regarding their opinions on the length of treatment.
Gottwalt, Trista, "Client Views About Length of Medicated Assisted Therapy for Opioid Use Disorder" (2021). Culminating Projects in Community Psychology, Counseling and Family Therapy. 83.